During the period of observations none of the patients reached the critical value of 200 cells/mm3, which is usually considered as the threshold under which to start a prophylaxis against opportunistic infections (such as Pneumocystis jirovecii pneumonia) and no change in the therapies drawn by CD4+ cell count declines alone has been made in the study population. The gene discussed is CD4; the disease is Opportunistic infection.